HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure
Clinical trial NCT05135364 · UNKNOWN
Trial details
- NCT number
- NCT05135364
- Sponsor
- Yue Han
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2022-10-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.